fluconazole has been researched along with Primary Peritonitis in 83 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We audited the effect of co-prescription of daily oral fluconazole with antibiotics in the Pan Thames centres on fungal peritonitis." | 9.15 | Does antifungal prophylaxis with daily oral fluconazole reduce the risk of fungal peritonitis in peritoneal dialysis patients? The Pan Thames Renal Audit. ( Davenport, A; Wellsted, D, 2011) |
| "Fluconazole prophylaxis prevents colonization and invasive intra-abdominal Candida infections in high-risk surgical patients." | 9.09 | Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. ( Bille, J; Calandra, T; Chapuis, G; Chiolero, R; Eggimann, P; Francioli, P; Geroulanos, S; Glauser, MP; Pannatier, A; Schilling, J; Schneider, R; Wu, MM, 1999) |
| "We observed very low rates of both bacterial peritonitis and FP, and prophylaxis with low-dose fluconazole seemed to confer protection against AR-FP." | 7.76 | Prophylaxis against fungal peritonitis in CAPD--a single center experience with low-dose fluconazole. ( Antony, SK; Gandhe, S; Nayak, KS; Prabhu, MV; Subhramanyam, SV, 2010) |
| " Fifteen months after the discontinuation of immunosuppressive therapy, Eschericia coli peritonitis developed, which was treated with ceftazidime intraperitoneally; he received fluconazole as prophylactic antifungal therapy during this period." | 7.72 | Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis. ( Dosekun, AK; Serna, JH; Wanger, A, 2003) |
| "Rats in Fp groups were given fluconazole in doses of 0 mg/kg, 3 mg/kg, 10 mg/kg, and 30 mg/kg by gavage 30 min before induction of peritonitis." | 7.72 | Fluconazole attenuates lung injury and mortality in a rat peritonitis model. ( Arshaduddin, M; Evans, DP; Jacobs, S; Khan, HA; Moutaery, AA; Tariq, M, 2003) |
| "(1) To determine the pharmacokinetics of sequential intravenous and enteral fluconazole in the serum of surgical intensive care unit (ICU) patients with deep mycoses." | 7.71 | Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function. ( Bruining, HA; Buijk, SL; Gyssens, IC; Mouton, JW; Touw, DJ; Verbrugh, HA, 2001) |
| "Candida peritonitis was treated with fluconazole in ten continuous ambulatory peritoneal dialysis (CAPD) patients without immediate removal of the peritoneal catheter." | 7.69 | Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter. ( Aguirre, R; González, O; Martinez, I; Montenegro, J; Saracho, R, 1995) |
| "Fluconazole proved effective in treating fungal peritonitis caused by Trichosporon cutaneum." | 7.67 | Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report. ( Ahlmén, J; Carlsson, L; Edebo, L; Eriksson, C; Torgersen, AK, 1989) |
| "Oral fluconazole was used as initial therapy in all patients, which was followed by catheter removal if peritonitis failed to improve." | 6.67 | Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. ( Chan, CY; Chan, TM; Cheng, IK; Cheng, SW; Lo, CY; Lo, WK, 1994) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 5.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Treatment with fluconazole alone has an effect comparable to intraperitoneal (IP) amphotericin B alone or IP amphotericin B combined with oral or intravenous fluconazole." | 5.32 | Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. ( Chen, CM; Ho, MW; Wang, JH; Yu, WL, 2004) |
| "Fungal peritonitis is a rare event in patients receiving peritoneal dialysis." | 5.30 | Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. ( Blowey, DL; Garg, UC; Kearns, GL; Warady, BA, 1998) |
| "We audited the effect of co-prescription of daily oral fluconazole with antibiotics in the Pan Thames centres on fungal peritonitis." | 5.15 | Does antifungal prophylaxis with daily oral fluconazole reduce the risk of fungal peritonitis in peritoneal dialysis patients? The Pan Thames Renal Audit. ( Davenport, A; Wellsted, D, 2011) |
| "To demonstrate whether fluconazole reduces multiple organ failure and mortality in early septic shock (<24 hrs)." | 5.10 | Fluconazole improves survival in septic shock: a randomized double-blind prospective study. ( Al Omar, NF; Jacobs, S; Price Evans, DA; Tariq, M, 2003) |
| "Fluconazole prophylaxis prevents colonization and invasive intra-abdominal Candida infections in high-risk surgical patients." | 5.09 | Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. ( Bille, J; Calandra, T; Chapuis, G; Chiolero, R; Eggimann, P; Francioli, P; Geroulanos, S; Glauser, MP; Pannatier, A; Schilling, J; Schneider, R; Wu, MM, 1999) |
| "Based on the high clinical suspicion of fungal peritonitis, fluconazole intraperitoneal (IP) was immediately given on the first day in addition to empirical antibiotics, that is, cefazolin and gentamycin IP." | 4.31 | A successful management of fungal peritonitis caused by Rhodotorula glutinis in CAPD patient, coincident with onychomycosis by Penicillium sp: Case report. ( Hustrini, NM; Panggabean, SD, 2023) |
| "Detection by PCR of all Candida species and of most fluconazole-resistant Candida species could improve the cost-effectiveness of fluconazole and echinocandin given to non-neutropenic patients with suspected peritoneal candidiasis in ICUs." | 3.85 | Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit. ( Berry, A; Georges, B; Iriart, X; Juillard-Condat, B; Massip, P; Molinier, L; Pagès, A, 2017) |
| " Clinical features and outcome were compared in 25 (41%) Candida-positive patients (6 (22%) fluconazole-resistant Candida glabrata) and 36 patients without Candida infection." | 3.81 | Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery. ( Chochillon, C; Desmard, M; Houze, S; Marmuse, JP; Montravers, P; Ribeiro-Parenti, L; Zappella, N, 2015) |
| "To describe the clinical management of a case of Candida albicans peritonitis in a dog and discuss the pathogenicity of Candida peritonitis along with treatment using the fungistatic agent, fluconazole." | 3.76 | Candida albicans peritonitis in a dog. ( Ong, RK; Raisis, AL; Swindells, KL, 2010) |
| "We observed very low rates of both bacterial peritonitis and FP, and prophylaxis with low-dose fluconazole seemed to confer protection against AR-FP." | 3.76 | Prophylaxis against fungal peritonitis in CAPD--a single center experience with low-dose fluconazole. ( Antony, SK; Gandhe, S; Nayak, KS; Prabhu, MV; Subhramanyam, SV, 2010) |
| " Fifteen months after the discontinuation of immunosuppressive therapy, Eschericia coli peritonitis developed, which was treated with ceftazidime intraperitoneally; he received fluconazole as prophylactic antifungal therapy during this period." | 3.72 | Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis. ( Dosekun, AK; Serna, JH; Wanger, A, 2003) |
| "Rats in Fp groups were given fluconazole in doses of 0 mg/kg, 3 mg/kg, 10 mg/kg, and 30 mg/kg by gavage 30 min before induction of peritonitis." | 3.72 | Fluconazole attenuates lung injury and mortality in a rat peritonitis model. ( Arshaduddin, M; Evans, DP; Jacobs, S; Khan, HA; Moutaery, AA; Tariq, M, 2003) |
| "(1) To determine the pharmacokinetics of sequential intravenous and enteral fluconazole in the serum of surgical intensive care unit (ICU) patients with deep mycoses." | 3.71 | Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function. ( Bruining, HA; Buijk, SL; Gyssens, IC; Mouton, JW; Touw, DJ; Verbrugh, HA, 2001) |
| "Candida peritonitis was treated with fluconazole in ten continuous ambulatory peritoneal dialysis (CAPD) patients without immediate removal of the peritoneal catheter." | 3.69 | Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter. ( Aguirre, R; González, O; Martinez, I; Montenegro, J; Saracho, R, 1995) |
| "Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B 1-2 mg and oral flucytosine or fluconazole 50 mg b." | 3.69 | Successful treatment of fungal peritonitis with intracatheter antifungal retention. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995) |
| "Fluconazole proved effective in treating fungal peritonitis caused by Trichosporon cutaneum." | 3.67 | Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report. ( Ahlmén, J; Carlsson, L; Edebo, L; Eriksson, C; Torgersen, AK, 1989) |
| "Oral fluconazole was used as initial therapy in all patients, which was followed by catheter removal if peritonitis failed to improve." | 2.67 | Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. ( Chan, CY; Chan, TM; Cheng, IK; Cheng, SW; Lo, CY; Lo, WK, 1994) |
| "Fungal peritonitis is a rare but serious complication in children on peritoneal dialysis (PD)." | 2.44 | Fungal peritonitis in children on peritoneal dialysis. ( Cornelissen, E; Monnens, L; Raaijmakers, R; Schröder, C; Warris, A, 2007) |
| "Micafungin was started empirically." | 1.40 | Fungemia due to Lachancea fermentati: a case report. ( Green, JS; Leuck, AM; Rothenberger, MK, 2014) |
| "Peritonitis is a common problem in patients undergoing peritoneal dialysis." | 1.38 | Successful treatment of peritonitis by C. bertholletiae in a chronic kidney failure patient on continuous ambulatory peritoneal dialysis after kidney rejection. ( Bhutada, K; Borkar, SS; Mendiratta, DK; Shende, VR, 2012) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 1.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Fungal peritonitis is a relatively uncommon complication of peritoneal dialysis that contributes significantly to morbidity, drop out from the continuous ambulatory peritoneal dialysis (CAPD) program, and mortality." | 1.35 | First case of continuous ambulatory peritoneal dialysis peritonitis due to Candida sake. ( Guclu, E; Kucukbayrak, A; Ozdemir, D; Soypacaci, Z; Yildirim, M, 2009) |
| "Fungal peritonitis has been usually associated with high morbidity, mortality and its treatment is difficult." | 1.35 | Acremonium spp. peritonitis in an infant. ( Atalay, S; Ciftçi, E; Düzenli, F; Ekim, M; Galip, N; Güriz, H; Kendirli, T; Ozçakar, ZB; Tapisiz, A; Tutar, E; Uçar, T, 2008) |
| "Diagnosis and treatment of Acanthamoeba infections are difficult due to the rarity of the infections, lack of familiarity of most clinicians with disease syndromes, and limitations of therapeutics options." | 1.35 | An unusual case of Acanthamoeba peritonitis in a malnourished patient on continuous ambulatory peritoneal dialysis (CAPD). ( Parekh, A; Prakash, J; Singh, RG; Tilak, R; Usha, U; Wani, IA, 2008) |
| "Fungal peritonitis is a rare cause of peritonitis, but it is associated to poorer prognosis and higher mortality than bacterial peritonitis." | 1.33 | [Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases]. ( Aparicio, M; García Ramón, R; Miguel, A; Molina, P; Puchades, MJ, 2005) |
| "Fungal peritonitis is rare among end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis (CAPD), but when it occurs, it is associated with a high risk of mortality and peritoneal membrane failure." | 1.32 | Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis. ( Chan, CK; Chow, VC; Lo, SH; Mo, KL; Shum, HP; Wong, KS, 2003) |
| "Treatment with fluconazole alone has an effect comparable to intraperitoneal (IP) amphotericin B alone or IP amphotericin B combined with oral or intravenous fluconazole." | 1.32 | Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. ( Chen, CM; Ho, MW; Wang, JH; Yu, WL, 2004) |
| "Peritonitis is a frequent complication in patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) treatment." | 1.32 | Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD). ( González-Monroy, J; Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ, 2003) |
| "Fungal peritonitis is rarely encountered." | 1.31 | Trichosporon beigelii peritonitis in a HIV-positive patient on continuous ambulatory peritoneal dialysis. ( Agarwal, SK; Anuradha, S; Bajaj, J; Chatterjee, A; Kaur, R; Singh, NP, 2000) |
| "Fungal peritonitis is a serious complication of chronic peritoneal dialysis (CPD) and is frequently associated with CPD drop-out." | 1.31 | Paecilomyces variotii peritonitis in an infant on automated peritoneal dialysis. ( Fiscarelli, E; Rinaldi, S; Rizzoni, G, 2000) |
| "Fungal peritonitis is a rare event in patients receiving peritoneal dialysis." | 1.30 | Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. ( Blowey, DL; Garg, UC; Kearns, GL; Warady, BA, 1998) |
| "Amphotericin B (amp B) was added when clinical sepsis was present." | 1.30 | Fungal peritonitis in pediatric patients. ( Abitbol, C; Coakley, S; Diaz, R; Mazza, I; Montane, BS; Strauss, J; Zilleruelo, G, 1998) |
| " In conclusion, from a pharmacokinetic point of view, all the antifungal agents examined, perhaps with the exception of F, do not offer, when used alone, sufficient guarantees in curing peritonitis." | 1.29 | Pharmacokinetics of antifungal agents. ( Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV, 1993) |
| "Fungal peritonitis is rare in our CPD population, and although it leads to significant CPD drop-out, it can be managed in many patients with antifungal therapy, early catheter removal, and temporary hemodialysis." | 1.29 | Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. ( Dunne, D; Finkelstein, FO; Goldie, SJ; Gorban-Brennan, N; Kiernan-Tridle, L; Kliger, AS; Torres, C, 1996) |
| "Fluconazole 200 mg was given orally (po) as first dose at the onset of antibiotic therapy, then 100 mg po every other day, and was continued for one week after the antibiotic therapy." | 1.29 | Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. ( Cabralda, T; Suh, H; Wadhwa, NK, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.61) | 18.7374 |
| 1990's | 34 (40.96) | 18.2507 |
| 2000's | 24 (28.92) | 29.6817 |
| 2010's | 21 (25.30) | 24.3611 |
| 2020's | 1 (1.20) | 2.80 |
| Authors | Studies |
|---|---|
| Panggabean, SD | 1 |
| Hustrini, NM | 1 |
| Pagès, A | 1 |
| Iriart, X | 1 |
| Molinier, L | 1 |
| Georges, B | 1 |
| Berry, A | 1 |
| Massip, P | 1 |
| Juillard-Condat, B | 1 |
| Lopes, K | 1 |
| Rocha, A | 2 |
| Rodrigues, A | 2 |
| Carvalho, MJ | 2 |
| Cabrita, A | 2 |
| Pea, F | 1 |
| Righi, E | 1 |
| Cojutti, P | 1 |
| Carnelutti, A | 1 |
| Baccarani, U | 1 |
| Soardo, G | 1 |
| Bassetti, M | 1 |
| Leuck, AM | 1 |
| Rothenberger, MK | 1 |
| Green, JS | 1 |
| Im, H | 1 |
| Chae, JD | 1 |
| Yoo, M | 1 |
| Lee, SY | 1 |
| Song, EJ | 1 |
| Sung, SA | 1 |
| Hwang, YH | 1 |
| Shin, JH | 1 |
| Cho, YU | 1 |
| Asano, M | 1 |
| Mizutani, M | 1 |
| Nagahara, Y | 1 |
| Inagaki, K | 1 |
| Kariya, T | 1 |
| Masamoto, D | 1 |
| Urai, M | 1 |
| Kaneko, Y | 1 |
| Ohno, H | 1 |
| Miyazaki, Y | 1 |
| Mizuno, M | 1 |
| Ito, Y | 1 |
| Krashin, E | 1 |
| Lishner, M | 1 |
| Chowers, M | 1 |
| Reisfeld, S | 1 |
| Zappella, N | 1 |
| Desmard, M | 1 |
| Chochillon, C | 1 |
| Ribeiro-Parenti, L | 1 |
| Houze, S | 1 |
| Marmuse, JP | 1 |
| Montravers, P | 1 |
| Li, WS | 1 |
| Lee, CH | 1 |
| Liu, JW | 1 |
| Martins, AR | 1 |
| Branco, P | 1 |
| Gaspar, A | 1 |
| Kim, M | 1 |
| Bae, EH | 1 |
| Kim, SW | 1 |
| Ma, SK | 1 |
| Guclu, E | 1 |
| Soypacaci, Z | 1 |
| Yildirim, M | 1 |
| Kucukbayrak, A | 1 |
| Ozdemir, D | 1 |
| Pérez Melón, C | 1 |
| Conde Rivera, O | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Tilak, R | 1 |
| Singh, RG | 1 |
| Wani, IA | 1 |
| Parekh, A | 1 |
| Prakash, J | 1 |
| Usha, U | 1 |
| Ong, RK | 1 |
| Raisis, AL | 1 |
| Swindells, KL | 1 |
| Khoury, W | 1 |
| Szold, O | 1 |
| Soffer, D | 1 |
| Kariv, Y | 1 |
| Wasserlauf, R | 1 |
| Klausner, JM | 1 |
| Ogorek, D | 1 |
| Weinbroum, AA | 1 |
| Prabhu, MV | 1 |
| Subhramanyam, SV | 1 |
| Gandhe, S | 1 |
| Antony, SK | 1 |
| Nayak, KS | 1 |
| Quintela Obregón, E | 1 |
| Palomar Fontanet, R | 1 |
| Salas, C | 1 |
| Rodrigo Calabia, E | 1 |
| Arias Rodríguez, M | 1 |
| Gallieni, M | 1 |
| Chiarelli, G | 1 |
| Olivi, L | 1 |
| Cozzolino, M | 1 |
| Cusi, D | 1 |
| Davenport, A | 1 |
| Wellsted, D | 1 |
| Khan, FY | 1 |
| Elsayed, M | 1 |
| Anand, D | 1 |
| Abu Khattab, M | 1 |
| Sanjay, D | 1 |
| Levallois, J | 1 |
| Nadeau-Fredette, AC | 1 |
| Labbé, AC | 1 |
| Laverdière, M | 1 |
| Ouimet, D | 1 |
| Vallée, M | 1 |
| Teixeira, L | 1 |
| Mendonça, D | 1 |
| Bhutada, K | 1 |
| Borkar, SS | 1 |
| Mendiratta, DK | 1 |
| Shende, VR | 1 |
| Lee, SC | 1 |
| Fung, CP | 1 |
| Chen, HY | 1 |
| Li, CT | 1 |
| Jwo, SC | 1 |
| Hung, YB | 1 |
| See, LC | 1 |
| Liao, HC | 1 |
| Loke, SS | 1 |
| Wang, FL | 1 |
| Lee, JC | 1 |
| Alvarez-Lerma, F | 1 |
| Nolla, J | 1 |
| Palomar, M | 1 |
| León, MA | 1 |
| Islam, S | 1 |
| Zaidi, AK | 1 |
| Wilson, J | 1 |
| Jacobs, S | 2 |
| Price Evans, DA | 1 |
| Tariq, M | 2 |
| Al Omar, NF | 1 |
| Serna, JH | 1 |
| Wanger, A | 1 |
| Dosekun, AK | 1 |
| Moutaery, AA | 1 |
| Arshaduddin, M | 1 |
| Khan, HA | 2 |
| Evans, DP | 1 |
| Manzano-Gayosso, P | 1 |
| Hernández-Hernández, F | 1 |
| Méndez-Tovar, LJ | 1 |
| González-Monroy, J | 1 |
| López-Martínez, R | 1 |
| Bava, AJ | 1 |
| Fayad, A | 1 |
| Céspedes, C | 1 |
| Sandoval, M | 1 |
| Chen, CM | 1 |
| Ho, MW | 1 |
| Yu, WL | 1 |
| Wang, JH | 1 |
| Molina, P | 1 |
| Puchades, MJ | 1 |
| Aparicio, M | 1 |
| García Ramón, R | 1 |
| Miguel, A | 1 |
| Freydiere, AM | 1 |
| Piens, MA | 1 |
| Andre, JM | 1 |
| Putet, G | 1 |
| Picot, S | 1 |
| Raaijmakers, R | 1 |
| Schröder, C | 1 |
| Monnens, L | 1 |
| Cornelissen, E | 1 |
| Warris, A | 1 |
| Lo, SH | 1 |
| Chan, CK | 1 |
| Shum, HP | 1 |
| Chow, VC | 1 |
| Mo, KL | 1 |
| Wong, KS | 1 |
| Kendirli, T | 1 |
| Ciftçi, E | 1 |
| Ekim, M | 1 |
| Galip, N | 1 |
| Düzenli, F | 1 |
| Ozçakar, ZB | 1 |
| Tapisiz, A | 1 |
| Uçar, T | 1 |
| Tutar, E | 1 |
| Güriz, H | 1 |
| Atalay, S | 1 |
| Montenegro, J | 1 |
| Aguirre, R | 1 |
| González, O | 1 |
| Martinez, I | 1 |
| Saracho, R | 1 |
| Struijk, DG | 1 |
| Boeschoten, EW | 1 |
| Krediet, RT | 1 |
| Kuijper, EJ | 1 |
| Aguado, JM | 1 |
| Hidalgo, M | 1 |
| Ridríguez-Tudela, JL | 1 |
| Vincent, F | 1 |
| Bensousan, TA | 1 |
| Leclercq, B | 1 |
| De Saedeleer, B | 1 |
| Sennesael, J | 1 |
| Van der Niepen, P | 1 |
| Verbeelen, D | 1 |
| Amici, G | 1 |
| Grandesso, S | 1 |
| Mottola, A | 1 |
| Virga, G | 1 |
| Teodori, T | 1 |
| Maresca, MC | 1 |
| Bocci, C | 1 |
| Quindós, G | 1 |
| Cabrera, F | 1 |
| Arilla, MC | 1 |
| Burgos, A | 1 |
| Ortiz-Vigón, R | 1 |
| Cañón, JL | 1 |
| Pontón, J | 1 |
| Michel, C | 1 |
| Courdavault, L | 1 |
| al Khayat, R | 1 |
| Viron, B | 1 |
| Roux, P | 1 |
| Mignon, F | 1 |
| Chan, TM | 2 |
| Chan, CY | 1 |
| Cheng, SW | 1 |
| Lo, WK | 2 |
| Lo, CY | 1 |
| Cheng, IK | 2 |
| Huang, TC | 1 |
| Chung, WK | 1 |
| Carpentier, JP | 1 |
| Petrognani, R | 1 |
| Erbslöh-Möller, B | 1 |
| Steinhoff, J | 1 |
| Sack, K | 1 |
| Hoch, BS | 1 |
| Namboodiri, NK | 1 |
| Banayat, G | 1 |
| Neiderman, G | 1 |
| Louis, BM | 1 |
| Manohar, NL | 1 |
| Lipner, HI | 1 |
| Fabris, A | 1 |
| Pellanda, MV | 1 |
| Gardin, C | 1 |
| Contestabile, A | 1 |
| Bolzonella, R | 1 |
| Lee, SH | 1 |
| Chiang, SS | 1 |
| Hseih, SJ | 1 |
| Shen, HM | 1 |
| Goldie, SJ | 1 |
| Kiernan-Tridle, L | 1 |
| Torres, C | 1 |
| Gorban-Brennan, N | 1 |
| Dunne, D | 1 |
| Kliger, AS | 1 |
| Finkelstein, FO | 1 |
| Melez, KA | 1 |
| Cherry, J | 1 |
| Sanchez, C | 1 |
| Ettinger, RB | 1 |
| Walsh, TJ | 1 |
| Wadhwa, NK | 1 |
| Suh, H | 1 |
| Cabralda, T | 1 |
| Eggimann, P | 1 |
| Francioli, P | 1 |
| Bille, J | 1 |
| Schneider, R | 1 |
| Wu, MM | 1 |
| Chapuis, G | 1 |
| Chiolero, R | 1 |
| Pannatier, A | 1 |
| Schilling, J | 1 |
| Geroulanos, S | 1 |
| Glauser, MP | 1 |
| Calandra, T | 1 |
| Lui, SL | 1 |
| Li, FK | 1 |
| Equils, O | 1 |
| Deville, JG | 1 |
| Shapiro, AM | 1 |
| Sanchez, CP | 1 |
| Heslet, L | 1 |
| Christensen, H | 1 |
| Blowey, DL | 1 |
| Garg, UC | 1 |
| Kearns, GL | 1 |
| Warady, BA | 1 |
| Montane, BS | 1 |
| Mazza, I | 1 |
| Abitbol, C | 1 |
| Zilleruelo, G | 1 |
| Strauss, J | 1 |
| Coakley, S | 1 |
| Diaz, R | 1 |
| Rinaldi, S | 1 |
| Fiscarelli, E | 1 |
| Rizzoni, G | 1 |
| Anuradha, S | 1 |
| Chatterjee, A | 1 |
| Bajaj, J | 1 |
| Singh, NP | 1 |
| Agarwal, SK | 1 |
| Kaur, R | 1 |
| Buijk, SL | 1 |
| Gyssens, IC | 1 |
| Mouton, JW | 1 |
| Verbrugh, HA | 1 |
| Touw, DJ | 1 |
| Bruining, HA | 1 |
| Kleinpeter, MA | 1 |
| Butt, AA | 1 |
| Morey, A | 1 |
| Lima, C | 1 |
| Matas, B | 1 |
| Munar, MA | 1 |
| Sandven, P | 1 |
| Qvist, H | 1 |
| Skovlund, E | 1 |
| Giercksky, KE | 1 |
| Morris, B | 1 |
| Chan, YF | 1 |
| Reddy, J | 1 |
| Woodgyer, A | 1 |
| Debruyne, D | 1 |
| Ryckelynck, JP | 1 |
| Snyder, S | 1 |
| Reuman, PD | 1 |
| Neiberger, R | 1 |
| Kondor, DA | 1 |
| Crompton, CH | 1 |
| Balfe, JW | 1 |
| Summerbell, RC | 1 |
| Silver, MM | 1 |
| Eisinger, RP | 1 |
| Weinstein, MP | 1 |
| Corbella, X | 1 |
| Sirvent, JM | 1 |
| Carratalá, J | 1 |
| Gibb, AP | 1 |
| Aggarwal, R | 1 |
| Swainson, CP | 1 |
| Venning, MC | 1 |
| Ford, M | 1 |
| Gould, FK | 1 |
| Abraham, G | 1 |
| Vas, SI | 1 |
| Levine, J | 1 |
| Bernard, DB | 1 |
| Idelson, BA | 1 |
| Farnham, H | 1 |
| Saunders, C | 1 |
| Sugar, AM | 1 |
| Thomas, MG | 1 |
| Ellis-Pegler, RB | 1 |
| Ahlmén, J | 1 |
| Edebo, L | 1 |
| Eriksson, C | 1 |
| Carlsson, L | 1 |
| Torgersen, AK | 1 |
4 reviews available for fluconazole and Primary Peritonitis
| Article | Year |
|---|---|
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echin | 2012 |
Fungal peritonitis in children on peritoneal dialysis.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Infan | 2007 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
Fungal peritonitis--current status 1998.
Topics: Antifungal Agents; Fluconazole; Humans; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Periton | 1999 |
5 trials available for fluconazole and Primary Peritonitis
| Article | Year |
|---|---|
Does antifungal prophylaxis with daily oral fluconazole reduce the risk of fungal peritonitis in peritoneal dialysis patients? The Pan Thames Renal Audit.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Fluconazole; Humans | 2011 |
Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Topics: Adult; Aged; Antifungal Agents; Cross Infection; Double-Blind Method; Female; Fluconazole; Hospital | 2003 |
Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients.
Topics: Administration, Oral; Amphotericin B; Female; Fluconazole; Humans; Injections, Intravenous; Male; Mi | 1994 |
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Critical Care; Dou | 1999 |
Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Double-Blind Method; Fem | 2002 |
74 other studies available for fluconazole and Primary Peritonitis
| Article | Year |
|---|---|
A successful management of fungal peritonitis caused by Rhodotorula glutinis in CAPD patient, coincident with onychomycosis by Penicillium sp: Case report.
Topics: Adult; Dialysis Solutions; Fluconazole; Humans; Male; Mycoses; Onychomycosis; Peritoneal Dialysis, C | 2023 |
Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cost-Benefit Analysis; Decision Trees; Drug Resistan | 2017 |
Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Catheter-Related Infections; Catheters, Indwel | 2013 |
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis.
Topics: Administration, Intravenous; Aged; Antifungal Agents; Ascites; Bile; Candida; Candidiasis; Fluconazo | 2014 |
Fungemia due to Lachancea fermentati: a case report.
Topics: Adult; Antifungal Agents; Echinocandins; Fluconazole; Fungemia; Hepatitis, Alcoholic; Humans; Immuno | 2014 |
First case of continuous ambulatory peritoneal dialysis-related peritonitis caused by Cryptococcus arboriformis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; DNA, Ribosomal; Fluconazole; Humans | 2014 |
Successful treatment of Cryptococcus laurentii peritonitis in a patient on peritoneal dialysis.
Topics: Adult; Antifungal Agents; Catheterization; Catheters, Indwelling; Cryptococcus; Device Removal; Echi | 2015 |
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
Topics: Antifungal Agents; Ascitic Fluid; Candida albicans; Escherichia coli; Fatal Outcome; Female; Flucona | 2015 |
Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery.
Topics: Adult; Ascitic Fluid; Bacteria; Bariatric Surgery; Candida; Candidiasis; Coinfection; Drug Resistanc | 2015 |
Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Ascitic Fluid; | 2017 |
Lactobacillus casei Peritonitis in Peritoneal Dialysis: A Rare Case and Literature Review.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Ascitic Fluid; Candida albicans; Fluconazole; Humans | 2016 |
Candida guilliermondii continuous ambulatory peritoneal dialysis peritonitis confirmed by 16s rRNA sequencing.
Topics: Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Fluconazole; Humans; Male; Middle Aged; Perito | 2016 |
First case of continuous ambulatory peritoneal dialysis peritonitis due to Candida sake.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Male; Peritoneal Dialysis, Cont | 2009 |
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Rem | 2009 |
An unusual case of Acanthamoeba peritonitis in a malnourished patient on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acanthamoeba; Amebiasis; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mal | 2008 |
Candida albicans peritonitis in a dog.
Topics: Animals; Antifungal Agents; Candidiasis; Dog Diseases; Dogs; Fluconazole; Male; Peritonitis; Surgica | 2010 |
Prophylactic fluconazole does not improve outcome in patients with purulent and fecal peritonitis due to lower gastrointestinal perforation.
Topics: Aged; Antifungal Agents; Dose-Response Relationship, Drug; Feces; Female; Fluconazole; Follow-Up Stu | 2010 |
Prophylaxis against fungal peritonitis in CAPD--a single center experience with low-dose fluconazole.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Peritoneal | 2010 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug | 2010 |
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Topics: Adult; Antifungal Agents; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Device Re | 2011 |
Fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis in Qatar.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida; Device Removal | 2011 |
Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Ceftazidime; Cohort | 2012 |
Successful treatment of peritonitis by C. bertholletiae in a chronic kidney failure patient on continuous ambulatory peritoneal dialysis after kidney rejection.
Topics: Antifungal Agents; Cunninghamella; Drug Administration Routes; Fluconazole; Follow-Up Studies; Graft | 2012 |
Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B.
Topics: Adult; Age Distribution; Aged; Amphotericin B; Ascitic Fluid; Candida; Cohort Studies; Female; Fluco | 2002 |
[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case Management; Consensus Development Conferences a | 2003 |
Peritoneal infection with multiple species of Candida: a case report.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; | 2002 |
Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Bacteroides fragilis; Combined Modality Therap | 2003 |
Fluconazole attenuates lung injury and mortality in a rat peritonitis model.
Topics: Adjuvants, Immunologic; Animals; Ascitic Fluid; Disease Models, Animal; Dose-Response Relationship, | 2003 |
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acremonium; Aged; Antifungal Agents; Aspergillus; Candida; Child; Drug Resistance, Fungal; Female; F | 2003 |
Fungal peritonitis caused by Bipolaris spicifera.
Topics: Antifungal Agents; Ascomycota; Catheterization; Child, Preschool; Female; Fluconazole; Humans; Mycos | 2003 |
Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Drug Therapy, Combination; Female; Fl | 2004 |
Effect of fluconazole on phagocytic response of polymorphonuclear leukocytes in a rat model of acute sepsis.
Topics: Analysis of Variance; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship | 2005 |
[Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Ca | 2005 |
Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Therapy, Combination; Fertilization in Vitro; | 2005 |
Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis.
Topics: Antifungal Agents; Candidiasis; China; Female; Fluconazole; Humans; Male; Middle Aged; Peritoneal Di | 2003 |
Acremonium spp. peritonitis in an infant.
Topics: Acremonium; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Down Syndrome; Fluconazole; He | 2008 |
Fluconazole treatment of candida peritonitis with delayed removal of the peritoneal dialysis catheter.
Topics: Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Humans; Kidney Failure, | 1995 |
Fluconazole in candida peritonitis in CAPD: an alternative proposal.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Peritoneal Dialysis, Co | 1995 |
Successful treatment of candida peritonitis with fluconazole.
Topics: Candidiasis; Fluconazole; Humans; Male; Middle Aged; Peritonitis | 1994 |
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: use of high dosages of fluconazole or solely removal of the catheter?
Topics: Candidiasis; Fluconazole; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1995 |
Intraperitoneal fluconazole therapy for Trichosporon cutaneum peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Aged; Ascitic Fluid; Fluconazole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Myco | 1994 |
Verticillium peritonitis in a patient on peritoneal dialysis.
Topics: Adult; Fluconazole; Flucytosine; Humans; Male; Mitosporic Fungi; Mycoses; Peritoneal Dialysis, Conti | 1994 |
Fatal Candida famata peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis who was treated with fluconazole.
Topics: Aged; Candidiasis; Drug Resistance, Microbial; Fatal Outcome; Fluconazole; Humans; Male; Peritoneal | 1994 |
Fluconazole in the treatment of candida peritonitis in continuous ambulatory peritoneal dialysis: report of a case.
Topics: Administration, Oral; Aged; Candidiasis; Female; Fluconazole; Humans; Peritoneal Dialysis, Continuou | 1993 |
[Peritoneal mucormycosis and fluconazole].
Topics: Aged; Female; Fluconazole; Humans; Mucormycosis; Peritonitis | 1993 |
[The treatment of Candida peritonitis during peritoneal dialysis].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Middle Aged; Pe | 1993 |
The use of fluconazole in the management of Candida peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluconazole; Humans; Male; Peritonitis | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritone | 1993 |
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytos | 1995 |
Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Catheters, Indwelling; Female; | 1996 |
Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Antifungal Agents; Ascitic Fluid; Fluconazole; Hu | 1995 |
Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients.
Topics: Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 1996 |
Penicillium peritonitis in an adolescent receiving chronic peritoneal dialysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Kidney Failure, Chronic; Peni | 1999 |
[Antimycotic therapy in secondary peritonitis prevents invasive mycosis].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Mycoses; Peritonitis | 1999 |
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
Topics: Amphotericin B; Antifungal Agents; Ascitic Fluid; Candidiasis; Drug Combinations; Drug Therapy, Comb | 1998 |
Fungal peritonitis in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Fluconazole; Hu | 1998 |
Paecilomyces variotii peritonitis in an infant on automated peritoneal dialysis.
Topics: Administration, Oral; Adolescent; Automation; Fluconazole; Humans; Injections, Intraperitoneal; Male | 2000 |
Trichosporon beigelii peritonitis in a HIV-positive patient on continuous ambulatory peritoneal dialysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Fluconazole; Follow-Up Studies; HIV Seropositivity; Hu | 2000 |
Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function.
Topics: Antifungal Agents; Area Under Curve; Biological Availability; Digestive System Surgical Procedures; | 2001 |
Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Device Removal; Equipm | 2001 |
[Fluconazole prophylaxis for fungal peritonitis in peritoneal dialysis].
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Diabetic Nephropathies; | 2001 |
Cryptococcal peritonitis in a CAPD patient.
Topics: Cryptococcosis; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Peritoneal Dialysis, Continu | 1992 |
Fluconazole serum, urine, and dialysate levels in CAPD patients.
Topics: Fluconazole; Humans; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1992 |
Peritonitis due to Saccharomyces cerevisiae in a patient on CAPD.
Topics: Adult; Fluconazole; Humans; Male; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; | 1992 |
Intraperitoneal and intravenous fluconazole pharmokinetics in a pediatric patient with end stage renal disease.
Topics: Candidiasis; Female; Fluconazole; Humans; Infant; Infusions, Intravenous; Kidney Failure, Chronic; P | 1992 |
Peritonitis with Paecilomyces complicating peritoneal dialysis.
Topics: Adolescent; Fluconazole; Humans; Male; Mycoses; Paecilomyces; Peritoneal Dialysis, Continuous Ambula | 1991 |
A bold mold? Paecilomyces variotii peritonitis during continuous ambulatory peritoneal dialysis.
Topics: Adult; Catheters, Indwelling; Female; Fluconazole; Humans; Kidney Failure, Chronic; Mycoses; Paecilo | 1991 |
Fluconazole treatment without catheter removal in Candida albicans peritonitis complicating peritoneal dialysis.
Topics: Adult; Candidiasis; Catheterization, Peripheral; Catheters, Indwelling; Fluconazole; Humans; Male; P | 1991 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middl | 1991 |
Successful treatment of fungal peritonitis in CAPD using oral fluconazole.
Topics: Administration, Oral; Candidiasis; Fluconazole; Humans; Mycoses; Peritoneal Dialysis, Continuous Amb | 1990 |
Treatment of fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Candidiasis; Catheters, Indwelling; Fluconazole; Humans; Peritoneal Dialysis, Continuous Ambulatory; | 1990 |
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.
Topics: Adult; Antifungal Agents; Candidiasis; Dialysis Solutions; Female; Fluconazole; Humans; Male; Middle | 1989 |
Fluconazole treatment of Candida glabrata peritonitis.
Topics: Adult; Candida; Candidiasis; Female; Fluconazole; Humans; Peritonitis; Triazoles | 1989 |
Fluconazole therapy for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a case report.
Topics: Fluconazole; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mycoses; Peritoneal Dialysis, Conti | 1989 |